7-Bromo-N-(3,5-difluorophenyl)-2-oxo-1,2-dihydroquinoline-4-carboxamide

ID: ALA4175488

Chembl Id: CHEMBL4175488

PubChem CID: 145952615

Max Phase: Preclinical

Molecular Formula: C16H9BrF2N2O2

Molecular Weight: 379.16

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cc(F)cc(F)c1)c1cc(=O)[nH]c2cc(Br)ccc12

Standard InChI:  InChI=1S/C16H9BrF2N2O2/c17-8-1-2-12-13(7-15(22)21-14(12)3-8)16(23)20-11-5-9(18)4-10(19)6-11/h1-7H,(H,20,23)(H,21,22)

Standard InChI Key:  VRPYTQLGCJQZDA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4175488

    ---

Associated Targets(Human)

KYSE-410 (210 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KYSE-70 cell line (224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 379.16Molecular Weight (Monoisotopic): 377.9815AlogP: 3.82#Rotatable Bonds: 2
Polar Surface Area: 61.96Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.73CX Basic pKa: CX LogP: 3.58CX LogD: 3.58
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.71Np Likeness Score: -1.33

References

1. Shahin MI, Roy J, Hanafi M, Wang D, Luesakul U, Chai Y, Muangsin N, Lasheen DS, Abou El Ella DA, Abouzid KA, Neamati N..  (2018)  Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma.,  155  [PMID:29908444] [10.1016/j.ejmech.2018.05.042]

Source